Landmark Bio, an Artis BioSolutions company dedicated to accelerating the translation of next-generation advanced therapies from discovery to clinical and commercial production, today announced that ...

Reframing pharmaceutical production around process stability, real-time quality assurance, and regulatory alignment in the ...

Moving away from fed-batch has significant sustainability and cost-saving benefits, according to industry working groups.

Dublin, March 02, 2026 (GLOBE NEWSWIRE) -- The "Continuous Manufacturing Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Drug Molecule, Stage of Bioprocessing, Type ...

Interest in intensified manufacturing is driving innovation in downstream technologies, according to the team behind a new predictive freeze-drying model designed with continuous processes in mind.

In recent years, fed-batch biomanufacturing has begun giving way to continuous manufacturing processes, as developers face pressure to balance affordability with high manufacturing quality. Although ...

Explore how parenteral manufacturing solutions are evolving for specific drug formulations and meeting the demands of ...

The antibiotic cefazolin is an essential drug according to the World Health Organization (WHO). It is usually produced via batch manufacturing, but this multistep process is time-consuming, wasteful ...

A 3-year research program, funded by the FDA, aims to design the first continuous mRNA-manufacturing platform. Faculty at the Massachusetts Institute of Technology (MIT; MA, USA) will be leading a ...